路 43% of Latino people reported symptoms of #LongCOVID in a new survey study published in Journal of General Internal Medicine
路 A case series for Long COVID using a combination of Paxlovid, valacyclovir (Valtrex) and celecoxib (Celebrex), was recently published in Frontiers of Immunology
路 A new phase II clinical trial for Long COVID was recently announced in the Netherlands
https://thesicktimes.org/2026/01/06/research-updates-january-6/
路 A large, electronic health records study published in JAMA Internal Medicine estimated that over 100,000 Americans died each year between 2022 and 2024 from #COVID19
路 A new study published in Molecular & Cellular Proteomics found further evidence of abnormalities in post-exertional malaise #PEM
路 A small phase two clinical trial is testing #Ketamine for #LongCOVID fatigue and cognitive function
https://thesicktimes.org/2026/01/13/research-updates-january-13/
